Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick
Analgesia with breastfeeding in addition to skin-to-skin contact during heel prick
复制标题
DOI:
10.1136/archdischild-2012-302921
复制
发表时间:
2013-11-01
影响因子:
4.4
通讯作者:
Medina Malagon, Lorena
中科院分区:
文献类型:
--
作者:
Marin Gabriel, Miguel Angel;del Rey Hurtado de Mendoza, Beatriz;Medina Malagon, Lorena
Objective To investigate the analgesic effect (measured with Neonatal Infant Pain Scale (NIPS)) of breastfeeding (BF) in addition to skin-to-skin contact (SSC) versus other methods of non-pharmacological analgesia during blood sampling through heel lance in healthy term neonates.Design Randomised controlled trial.Setting Tertiary level maternity ward.Patients One hundred thirty-six healthy term newborns. Inclusion criteria: healthy term neonates, wish to breastfeed and absence of feeding during the previous 60min.Intervention Neonates were randomly assigned to four groups: Group breastfed with SSC (BF+SSC Group) (n=35); Group sucrose with SSC (Sucrose+SSC Group) (n=35); SSC Group (n=33); or Sucrose Group (n=33). Babies were recorded with a video camera.Outcome measures Three observers watched the videos and measured NIPS score at three time points (t(0): 2min before heel prick; t(1): During heel prick; and t(2): 2min after the heel prick). The influences of non-pharmacological methods on crying time, percentage of crying while sampling, heart rate, number of attempts and duration of sampling were also studied.Results BF+SSC Group achieved a significant lower median NIPS score (value=1) compared with other groups (value=2, 4 and 4, respectively). The percentage of neonates with moderate-to-severe pain was also lower in the BF+SSC Group. Both groups BF+SSC and Sucrose+SSC achieved a significant lower percentage of crying compared with SSC Group.Conclusions This study suggests that BF in addition to SSC provides superior analgesia to other kinds of non-pharmacological analgesia in healthy term neonates during heel prick.Trial registration number (ClinicalTrials.gov): NCT01576432